105 related articles for article (PubMed ID: 27633040)
1. Tetramethypyrazine inhibits renal cell carcinoma cells through inhibition of NKG2D signaling pathways.
Luan Y; Liu J; Liu X; Xue X; Kong F; Sun C; Wang J; Liu L; Jia H
Int J Oncol; 2016 Oct; 49(4):1704-12. PubMed ID: 27633040
[TBL] [Abstract][Full Text] [Related]
2. Regulation Roles of MICA and NKG2D in Human Renal Cancer Cells.
Jia HY; Liu JL; Yuan MZ; Zhou CJ; Sun WD; Zhao JJ; Wang J; Liu L; Luan Y
Asian Pac J Cancer Prev; 2015; 16(9):3901-5. PubMed ID: 25987057
[TBL] [Abstract][Full Text] [Related]
3. Anti-proliferation effects and molecular mechanisms of action of tetramethypyrazine on human SGC-7901 gastric carcinoma cells.
Ji AJ; Liu SL; Ju WZ; Huang XE
Asian Pac J Cancer Prev; 2014; 15(8):3581-6. PubMed ID: 24870761
[TBL] [Abstract][Full Text] [Related]
4. Effect of 4,5-diazafluorene derivative on γδ T cell-mediated cytotoxicity against renal cell carcinoma.
Wen X; Wu Y; Tanaka Y; Awadasseid A; Tao H; Zhang W
Life Sci; 2021 Mar; 269():119066. PubMed ID: 33460663
[TBL] [Abstract][Full Text] [Related]
5. Matrix metallopeptidase 2 (MMP2) mediates MHC class I polypeptide-related sequence A (MICA) shedding in renal cell carcinoma.
Yang FQ; Liu M; Yang FP; Zhang XL; Yang B; Guo CC; Huang JH; Che JP; Yan Y; Zheng JH
Actas Urol Esp; 2014 Apr; 38(3):172-8. PubMed ID: 24461475
[TBL] [Abstract][Full Text] [Related]
6. Gallic acid suppresses the progression of clear cell renal cell carcinoma through inducing autophagy via the PI3K/Akt/Atg16L1 signaling pathway.
Zhang T; Zhang X; Fei Y; Lu J; Zhou D; Zhang L; Fan S; Zhou J; Liang C; Su Y
Int J Oncol; 2024 Jul; 65(1):. PubMed ID: 38818827
[TBL] [Abstract][Full Text] [Related]
7. Interferon-gamma down-regulates NKG2D ligand expression and impairs the NKG2D-mediated cytolysis of MHC class I-deficient melanoma by natural killer cells.
Schwinn N; Vokhminova D; Sucker A; Textor S; Striegel S; Moll I; Nausch N; Tuettenberg J; Steinle A; Cerwenka A; Schadendorf D; Paschen A
Int J Cancer; 2009 Apr; 124(7):1594-604. PubMed ID: 19089914
[TBL] [Abstract][Full Text] [Related]
8. The MICA-NKG2D axis in clear cell renal cell carcinoma bolsters MICA as target in immuno-oncology.
Secchiari F; Nuñez SY; Sierra JM; Ziblat A; Regge MV; Raffo Iraolagoitia XL; Rovegno A; Ameri C; Secin FP; Richards N; Ríos Pita H; Vitagliano G; Rico L; Mieggi M; Frascheri F; Bonanno N; Blas L; Trotta A; Friedrich AD; Fuertes MB; Domaica CI; Zwirner NW
Oncoimmunology; 2022; 11(1):2104991. PubMed ID: 35936986
[TBL] [Abstract][Full Text] [Related]
9. NOTCH1 functions as an oncogene by regulating the PTEN/PI3K/AKT pathway in clear cell renal cell carcinoma.
Liu S; Ma X; Ai Q; Huang Q; Shi T; Zhu M; Wang B; Zhang X
Urol Oncol; 2013 Aug; 31(6):938-48. PubMed ID: 21993533
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA-218 inhibits cell migration and invasion in renal cell carcinoma through targeting caveolin-2 involved in focal adhesion pathway.
Yamasaki T; Seki N; Yoshino H; Itesako T; Hidaka H; Yamada Y; Tatarano S; Yonezawa T; Kinoshita T; Nakagawa M; Enokida H
J Urol; 2013 Sep; 190(3):1059-68. PubMed ID: 23454155
[TBL] [Abstract][Full Text] [Related]
11. Taxanes enhance trastuzumab-mediated ADCC on tumor cells through NKG2D-mediated NK cell recognition.
Di Modica M; Sfondrini L; Regondi V; Varchetta S; Oliviero B; Mariani G; Bianchi GV; Generali D; Balsari A; Triulzi T; Tagliabue E
Oncotarget; 2016 Jan; 7(1):255-65. PubMed ID: 26595802
[TBL] [Abstract][Full Text] [Related]
12. NDRG2 is involved in the oncogenic properties of renal cell carcinoma and its loss is a novel independent poor prognostic factor after nephrectomy.
Liang ZL; Kang K; Yoon S; Huang SM; Lim JS; Kim JM; Lim JS; Lee HJ
Ann Surg Oncol; 2012 Aug; 19(8):2763-72. PubMed ID: 22246425
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of glycogen synthase kinase-3 increases NKG2D ligand MICA expression and sensitivity to NK cell-mediated cytotoxicity in multiple myeloma cells: role of STAT3.
Fionda C; Malgarini G; Soriani A; Zingoni A; Cecere F; Iannitto ML; Ricciardi MR; Federico V; Petrucci MT; Santoni A; Cippitelli M
J Immunol; 2013 Jun; 190(12):6662-72. PubMed ID: 23686482
[TBL] [Abstract][Full Text] [Related]
14. Sinomenine hydrochloride attenuates the proliferation, migration, invasiveness, angiogenesis and epithelial-mesenchymal transition of clear-cell renal cell carcinoma cells via targeting Smad in vitro.
Zhao B; Liu L; Mao J; Liu K; Fan W; Liu J; Zhang Z; Li Q
Biomed Pharmacother; 2017 Dec; 96():1036-1044. PubMed ID: 29198924
[TBL] [Abstract][Full Text] [Related]
15. Epithelial-mesenchymal transition induces an antitumor immune response mediated by NKG2D receptor.
López-Soto A; Huergo-Zapico L; Galván JA; Rodrigo L; de Herreros AG; Astudillo A; Gonzalez S
J Immunol; 2013 Apr; 190(8):4408-19. PubMed ID: 23509364
[TBL] [Abstract][Full Text] [Related]
16. Thymoquinone inhibits metastatic phenotype and epithelial‑mesenchymal transition in renal cell carcinoma by regulating the LKB1/AMPK signaling pathway.
Kou B; Kou Q; Ma B; Zhang J; Sun B; Yang Y; Li J; Zhou J; Liu W
Oncol Rep; 2018 Sep; 40(3):1443-1450. PubMed ID: 29956793
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of bcl-2 enhances the efficacy of chemotherapy in renal cell carcinoma.
Kausch I; Jiang H; Thode B; Doehn C; Krüger S; Jocham D
Eur Urol; 2005 May; 47(5):703-9. PubMed ID: 15826766
[TBL] [Abstract][Full Text] [Related]
18. KDM6B induces epithelial-mesenchymal transition and enhances clear cell renal cell carcinoma metastasis through the activation of SLUG.
Li Q; Hou L; Ding G; Li Y; Wang J; Qian B; Sun J; Wang Q
Int J Clin Exp Pathol; 2015; 8(6):6334-44. PubMed ID: 26261509
[TBL] [Abstract][Full Text] [Related]
19. Suppressive effects of microRNA-16 on the proliferation, invasion and metastasis of hepatocellular carcinoma cells.
Wu WL; Wang WY; Yao WQ; Li GD
Int J Mol Med; 2015 Dec; 36(6):1713-9. PubMed ID: 26499886
[TBL] [Abstract][Full Text] [Related]
20. Astragaloside IV inhibits metastasis in hepatoma cells through the suppression of epithelial-mesenchymal transition via the Akt/GSK-3β/β-catenin pathway.
Qin CD; Ma DN; Ren ZG; Zhu XD; Wang CH; Wang YC; Ye BG; Cao MQ; Gao DM; Tang ZY
Oncol Rep; 2017 Mar; 37(3):1725-1735. PubMed ID: 28112375
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]